*No clinical data are available that evaluate the long-term impact of RESILIA tissue in patients
Important Safety Information: KONECT RESILIA Aortic Valved Conduit
Indications: For use in replacement of native or prosthetic aortic heart valves and the associated repair or replacement of a damaged or diseased ascending aorta. Contraindications: There are no known contraindications with the use of the KONECT RESILIA aortic valved conduit. Complications and Side Effects: Thromboembolism, valve thrombosis, hemorrhage, hemolysis, regurgitation, endocarditis, structural valve deterioration, nonstructural dysfunction, stenosis, arrhythmia, transient ischemic attack/stroke, congestive heart failure, myocardial infarction, any of which could lead to reoperation, explantation, permanent disability, and death. Adverse events potentially associated with the use of polyester vascular grafts include hemorrhage, thrombosis, graft infection, embolism, aneurysm, pseudoaneurysm, seroma, occlusion (anastomotic intimal hyperplasia), immunological reaction to collagen (shown to be a weak immunogen; infrequent, mild, localized and self-limiting), intimal peel formation, and conduit dilatation.
CAUTION: Federal (USA) law restricts this device to sale by or on the order of a physician. See instructions for use for full prescribing information.
© 2019 Edwards Lifesciences Corporation. All rights reserved. PP--US-4230 v.1.0
Edwards Lifesciences • One Edwards Way, Irvine CA 92614 USA • edwards.com
This window will automatically close in seconds